Ceftaroline Fosamil Pd.C.So.In 600mg/Vial (under development)

Ceftaroline Fosamil Pd.C.So.In 600mg/Vial (under development)
Product Description

Ceftaroline Fosamil Powder for Concentrate for Solution for Infusion 600mg/vial
Reference Product: Zinforo® / Pfizer
Description: For the treatment of the following infections in neonates, infants, children, adolescents and adults, Complicated skin and soft tissue infections (cSSTI),  Community-acquired pneumonia (CAP), Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Dossier Status: On-going 
Stability Studies: Zone II / Zone IVb
Shelf life (Originator): Three (3) years
Batch Size: To be defined
Pack Sizes: To be defined / Originator pack: BT x 10 Vials

Read more Show less

ANFARM HELLAS S.A.

  • GR
  • 2015
    On CPHI since
View company profile
Categories
more categories Show less
Specifications
  • Supplied from
    Greece
More specifications Fewer specifications
Sales Markets
Show more Show less

ANFARM HELLAS S.A.

  • GR
  • 2015
    On CPHI since
View company profile

More Products from ANFARM HELLAS S.A. (36)

  • Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab (under development)

    Product Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab (under development)

    Apixaban Film Coated Tablets 2.5mg & 5mg
    Reference Product: Eliquis® / Bristol-Myers Squibb/Pfizer
    Description: Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transie...
  • Azithromycin Pd.Sol.Inf 500mg/Vial (EU CTD Available)

    Product Azithromycin Pd.Sol.Inf 500mg/Vial (EU CTD Available)

    Azithromycin 500mg/Vial Powder for Solution for Infusion Reference Product: Zithromax® / PFIZER 
    Description: Azithromycin as powder for solution for infusion is indicated for the treatment of community-acquired pneumonia due to susceptible microorganisms in adult patients where initial intrav...
  • Brivaracetam Oral Solution 10mg/ml (EU CTD Available: Q4 2022)

    Product Brivaracetam Oral Solution 10mg/ml (EU CTD Available: Q4 2022)

    Brivaracetam 10mg/ml Oral Solution
    Reference Product: Briviact® / UCB
    Description: Brivaracetam is an antiepileptic agent which is indicated as adjunctive therapy in the treatment of partial onsetseizures with or without secondary generalization in adults, adolescents and children from 4 year...
  • Brivaracetam Sol. Inf 10mg/ml (5ml Vial) (EU CTD Available: Q3 2022)

    Product Brivaracetam Sol. Inf 10mg/ml (5ml Vial) (EU CTD Available: Q3 2022)

    Brivaracetam 10mg/ml (5ml Vial) Solution for Injection/Infusion
    Reference Product: Briviact® / UCB
    Description: Brivaracetam is an antiepileptic agent which is indicated as adjunctive therapy in the treatment of partial onsetseizures with or without secondary generalization in adults, adolescents and...
  • Butamirate Syr 7.5mg/5ml (200ml Bottle) (EU CTD Available)

    Product Butamirate Syr 7.5mg/5ml (200ml Bottle) (EU CTD Available)

    Butamirate Syrup 7.5mg/5ml (200ml Bottle)  
    Reference Product: Sinecod ®/ NovartisDescription: Butamiratе Syrup is used for the symptomatic treatment of non-productive (dry) cough.
    Dossier Status: EU CTD Available
    Stability Studies: Zone II / Zone I...
  • Caspofungin Pd.C.So.In 50mg/Vial & 70mg/Vial (EU CTD Available)

    Product Caspofungin Pd.C.So.In 50mg/Vial & 70mg/Vial (EU CTD Available)

    Caspofungin 50 & 70 mg/Vial Powder for Concentrate for Solution for Infusion
    Reference Product: Cancidas® / MSD
    Description: Antifungal, used for the treatment of invasive candidiasis in adult or pediatric patients, invasive aspergillosis in adultor pediatric patients who are refractory to or int...
  • Ceftriaxone Ps.Inj.Sol 1g/Vial (IM, IV) (EU CTD Available)

    Product Ceftriaxone Ps.Inj.Sol 1g/Vial (IM, IV) (EU CTD Available)

    Ceftriaxone 1g/Vial Powder for Solution for Injection/Infusion 
    Reference Product: Farcef®  / Angelini
    Description: Ceftriaxone is a cephalosporin antibacterial indicated for the treatment of the following infections caused by susceptible isolates of the desig...
  • Cefuroxime Pd.Inj.Sol 750mg/Vial & 1.5g/Vial (EU CTD Available)

    Product Cefuroxime Pd.Inj.Sol 750mg/Vial & 1.5g/Vial (EU CTD Available)

    Cefuroxime 750mg /Vial & 1.5g/Vial Powder for Solution for Injection 
    Reference Product: Zinadol® / GSK
    Description: Cefuroxime is an antibiotic used to treat certain infections caused by bacteria, including respiratory-tract infections such as tonsillitis and pharyngitis (infections...
  • Clarithromycin Pd.Sol.Inf. 500mg/Vial (EU CTD Available)

    Product Clarithromycin Pd.Sol.Inf. 500mg/Vial (EU CTD Available)

    Clarithromycin 500mg/Vial Powder for Solution for Infusion Reference Product: Klaricid® / ABBOTT
    Description: Clarithromycin has a longer serum half-life and better tissue penetration than erythromycin, allowing twice-a-day dosing for most common infections.  Clarithromycin as a powder for sol...
  • Clindamycin Solution for Injection 150mg/ml (EU CTD Available: 2022)

    Product Clindamycin Solution for Injection 150mg/ml (EU CTD Available: 2022)

    Clindamycin 150mg/ml Solution for Injection (2ml & 4ml amps)  Dalacin® / PfizerDescription: Antibacterial.  Serious infections caused by susceptible Gram-positive organisms, staphylococci (both penicillinase- and non-penicillinase-producing), streptococci (except Streptococcus faecalis) ...
  • Daptomycin Pd.I.S.Inf. 350 & 500mg/Vial (EU CTD Available)

    Product Daptomycin Pd.I.S.Inf. 350 & 500mg/Vial (EU CTD Available)

    Daptomycin 350 & 500mg/Vial Powder for Solution for Injection or Infusion
    Reference Product: Cubicin® / MSD Description:Daptomycin is an antibacterial (cyclic lipopeptide natural product) that is active against Gram positive bacteria and is indicated for the treatment of the following infe...
  • Digoxin Inj.Sol. 0.25mg/ml (2ml Amp) (EU CTD Available)

    Product Digoxin Inj.Sol. 0.25mg/ml (2ml Amp) (EU CTD Available)

    Digoxin 0.25mg/ml Solution for Injection (2ml Amp)
    Reference Product: Lanoxin® / GSK
    Description: Digoxin is indicated in the management of chronic cardiac failure especially where cardiac failure is accompanied by atrial fibrillation, Supraventricular arrhythmias particularly ...
show all 36 other products

ANFARM HELLAS S.A. resources (2)